Literature DB >> 2786980

Preoperative correlates of impaired wound healing after saphenous vein excision.

J R Utley1, M E Thomason, D J Wallace, D W Mutch, L Staton, V Brown, C M Wilde, M S Bell.   

Abstract

Although major wound complications after saphenous vein excision are infrequent, we have found broadly defined impairment in leg wound healing to be relatively common. Wound healing impairment is defined in this study as inflammation, separation, cellulitis, lymphangitis, drainage, necrosis, or abscess necessitating dressing, antibiotics, or débridement before wound healing with complete epithelialization without eschar. Healing was impaired in 245 of 1047 patients (24.3%). Significant correlations were found between impaired wound healing and female sex (p less than 0.005), body mass index (obesity) (p less than 0.005), diabetes mellitus (p less than 0.005), left ventricular end-diastolic pressure greater than 15 mm Hg (p = 0.0074), arterial occlusive disease of the legs (p = 0.0124), and preoperative hematocrit value (p = 0.0491).

Entities:  

Mesh:

Year:  1989        PMID: 2786980

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  14 in total

1.  Early outcomes of radial artery use in all-arterial grafting of the coronary arteries in patients 65 years and older.

Authors:  Nevzat Erdil; Vedat Nisanoglu; Tamer Eroglu; Iyad Fansa; Hasan Berat Cihan; Bektas Battaloglu
Journal:  Tex Heart Inst J       Date:  2010

2.  The history of arterial revascularization: from Kolesov to Tector and beyond.

Authors:  Brian F Buxton; Sean D Galvin
Journal:  Ann Cardiothorac Surg       Date:  2013-07

3.  Endoscopic vein harvest in elective off-pump coronary artery bypass grafting.

Authors:  Nai-kuan Chou; Meng-lin Lee; Shoei-shen Wang
Journal:  J Zhejiang Univ Sci B       Date:  2009-10       Impact factor: 3.066

4.  Endoscopic harvesting of the greater saphenous vein for aortocoronary bypass grafting.

Authors:  G J Carrizo; J J Livesay; L Luy
Journal:  Tex Heart Inst J       Date:  1999

5.  Secondary surgical-site infection after coronary artery bypass grafting: A multi-institutional prospective cohort study.

Authors:  Brian C Gulack; Katherine A Kirkwood; Wei Shi; Peter K Smith; John H Alexander; Sandra G Burks; Annetine C Gelijns; Vinod H Thourani; Daniel Bell; Ann Greenberg; Seth D Goldfarb; Mary Lou Mayer; Michael E Bowdish
Journal:  J Thorac Cardiovasc Surg       Date:  2017-12-06       Impact factor: 5.209

6.  Cutaneous closure after cardiac operations: a controlled, randomized, prospective comparison of intradermal versus staple closures.

Authors:  R G Johnson; W E Cohn; R L Thurer; J R McCarthy; C A Sirois; R M Weintraub
Journal:  Ann Surg       Date:  1997-11       Impact factor: 12.969

7.  Unilayer Closure of Saphenous Vein Incision Lines is Better than Bilayer Closure.

Authors:  Osman Tiryakioglu; Tugrul Goncu; Gunduz Yumun; Onder Bozkurt; Ahmet Demir; Selma Kenar Tiryakioglu; Ahmet Ozyazicioglu; Senol Yavuz
Journal:  Open Cardiovasc Med J       Date:  2010-12-10

8.  Saphenous vein endothelial cell viability: a comparative study of endoscopic and open saphenectomy for coronary artery bypass grafting.

Authors:  S J Alrawi; R Raju; G Alshkaki; A J Acinapura; J N Cunningham
Journal:  JSLS       Date:  2001 Jan-Mar       Impact factor: 2.172

9.  Endoscopic Saphenous harvesting with an Open CO2 System (ESOS) trial for coronary artery bypass grafting surgery: study protocol for a randomized controlled trial.

Authors:  Antonio Campanella; Laura Bergamasco; Luigia Macri; Sofia Asioli; Roger Devotini; Serenella Scipioni; Silvana Barbaro; Pietro Rispoli; Mauro Rinaldi
Journal:  Trials       Date:  2011-11-18       Impact factor: 2.279

10.  Prospective randomized study comparing the Teleflex Medical SaphLITE Retractor to the Ethicon CardioVations Clearglide Endoscopic System.

Authors:  Scot C Schultz; Dennis Stapleton; Paula D'Ambra; Cynthia Loftis; Christine Wahrmann; George Ebra
Journal:  J Cardiothorac Surg       Date:  2006-09-06       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.